Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Korea Business Times.
Press releases published on April 30, 2025

Communiqué de presse : Sanofi et CD&R finalisent la cession d’Opella et créent un leader mondial de la santé grand public
Sanofi et CD…

Fitch updates Marex’s outlook to positive due to strong earnings and diversification of franchise
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Fitch Ratings (Fitch) yesterday announced that it has revised the outlook of Marex Group plc’s Long-Term Issuer Default Rating (IDR) to positive from stable, and has affirmed its Long-Term IDR at ‘BBB-’. The …

EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025
WATERTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today …

BioCryst to Present at Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Citizens Life Sciences Conference in New York on Thursday, May 8, …

MADD Canada’s Cpl. Cumming’s Watch Awards Honour Alberta Police Officers for their Efforts to Stop Impaired Driving
EDMONTON, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- MADD Canada will honour Alberta police officers who have played a vital role in removing impaired drivers from the province’s roads. During the Cpl. Cumming’s Watch ceremony taking place today at Royal …

Les prix Cpl. Cumming's Watch de MADD Canada rendent hommage aux policiers albertains pour leurs efforts visant à contrer la conduite avec capacités affaiblies
EDMONTON, Alberta, 30 avr. 2025 (GLOBE NEWSWIRE) -- MADD Canada rendra hommage aux policiers albertains qui ont joué un rôle essentiel dans le retrait des conducteurs aux capacités affaiblies des routes de la province. Au cours de la cérémonie Cpl. Cumming …

Stingray publiera ses résultats financiers pour le quatrième trimestre de l’exercice 2025
MONTRÉAL, 30 avr. 2025 (GLOBE NEWSWIRE) -- Le Groupe Stingray Inc. (TSX: RAY.A; RAY.B) publiera ses résultats financiers pour le quatrième trimestre clos le 31 mars 2025, le mardi 10 juin 2025, après la fermeture des marchés financiers. La direction …

OTC Markets Group Welcomes Datatec Ltd to OTCQX
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Datatec Ltd (JSE: DTC; OTCQX: DTTLF, DTTLY), an international ICT …

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
RAMSEY, N.J. and BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing …

Quebec's Digital Economy Could Employ a Quarter of Canada’s Tech Workers by 2030: New ICTC Report
MONTREAL, April 30, 2025 (GLOBE NEWSWIRE) -- Quebec’s digital economy could employ a quarter of Canada’s technology workers by 2030. A new report from the Information and Communications Technology Council (ICTC) presents a six-year outlook on Quebec’s …

Chicago Atlantic BDC, Inc. Announces First Quarter 2025 Financial Results Conference Call
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced details for the release of its financial …

Larimar Therapeutics Reports First Quarter 2025 Financial Results
FDA stated as part of a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval BLA seeking accelerated approval planned to be submitted by year-end …

Eloro Resources Announces Restart of Definition Drilling Targeting Major Tin Discovery and High Grade Silver Zones at its Iska Iska Ag-Sn-Polymetallic Project, Potosi Department, Bolivia
A new definition drill program comprised of 4,300m of diamond drilling in 8 holes that will commence shortly is focussed on upgrading and expanding high grade tin mineralization hosted in intrusion and phreatomagmatic breccia (TIB and TPMB, respectively) …

Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 8:30 …

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025
POMPANO BEACH, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces it …

AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update Continuing to advance clinical active immunotherapy portfolio for precision prevention of neurodegenerative diseases Positive immunogenicity and good safety in interim …

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
Sanofi and CD…

ECARX Announces First Quarter 2025 Unaudited Financial Results
SHANGHAI, April 30, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the quarter ended March 31, 2025. “The strong momentum we built …

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
WAYNE, Pa. and ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Dr. Garry Neil, Chief Executive Officer …

Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …